Well Referenced

Tag: risk assessment

The Association Between Urinary Cadmium Levels and Dietary Habits with Risk of Gastrointestinal Cancer in Tabriz, Northwest of Iran

This case-control study investigated the relationship between urinary cadmium (U-Cd) levels, dietary habits, and the risk of gastrointestinal (GI) cancer among 111 patients with GI cancer and 111 healthy controls in Tabriz, Iran. Urinary cadmium concentrations were measured using graphite furnace atomic absorption spectrophotometry. The study found that GI cancer

Read More »
June 26, 2025 No Comments

Quantitative Health Risk Assessment of Indoor Radon: A Systematic Review

This 2017 systematic review evaluates the global health risks associated with indoor radon exposure, a recognized cause of lung cancer. Analyzing 16 studies from 12 countries, the review identifies significant variability in radon concentrations and risk assessment models. By standardizing the attributable fraction (AF) calculations using a coefficient of 16%

Read More »
June 26, 2025 No Comments

High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus

This review explores the potential of high-sensitivity C-reactive protein (hsCRP) as an independent predictor of cardiovascular events in patients with diabetes mellitus. By assessing systemic inflammation, hsCRP levels offer clinicians a valuable tool for identifying diabetic individuals at elevated cardiovascular risk, improving risk stratification and informing targeted preventive strategies.

Read More »
June 26, 2025 No Comments

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

This 2003 practice guideline published in Circulation (DOI: 10.1161/01.cir.0000052939.59093.45) by the CDC and AHA evaluates the clinical relevance of inflammatory markers, particularly high-sensitivity C-reactive protein (hs-CRP), in assessing cardiovascular disease (CVD) risk. It concludes that hs-CRP is a useful tool for identifying low-grade systemic inflammation and may enhance cardiovascular risk

Read More »
June 26, 2025 No Comments

Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA)

This cohort study from the Multi-Ethnic Study of Atherosclerosis (MESA) evaluated the association between coronary artery calcium (CAC) scores and the 10-year risk of atherosclerotic cardiovascular disease (ASCVD) events in 6,783 participants from diverse ethnic backgrounds. The findings demonstrated that individuals with CAC scores of 0 had ASCVD event rates

Read More »
June 26, 2025 No Comments

8-Hydroxy-2-Deoxyguanosine Levels and Cardiovascular Disease: A Systematic Review and Meta-Analysis of the Literature

This meta-analysis examined the association between 8-hydroxy-2-deoxyguanosine (8-OHdG) levels and cardiovascular disease (CVD), analyzing 14 studies with 810 CVD patients and 1,106 controls. Results showed significantly higher 8-OHdG levels in CVD patients compared to controls (standard mean difference: 1.04, 95% CI: 0.61–1.47, p < 0.001), with elevated levels observed in

Read More »
June 26, 2025 No Comments

Hormone therapy and breast cancer risk

This article reviews the ongoing concerns surrounding hormone therapy (HT) for menopausal symptoms, particularly its association with an increased risk of breast cancer. While HT is the most effective treatment for alleviating symptoms like hot flashes, it has been linked to higher breast cancer risk, depending on factors such as

Read More »
June 26, 2025 No Comments